EUVIMEDEUVIMED entdecken
Crossref

Olanzapine‐induced weight gain and lipid dysfunction in mice between different gender

Tong Zhu iD, Hongxia Zhao, Yufan Chao, Songyan Gao iD, Xin Dong, Zuowei Wang

Biomedical Chromatography · 2024

DOI: 10.1002/bmc.5864 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Chromatography, 2024. Verfasst von Tong Zhu und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Shanghai University, Shanghai, China. Hauptthemen laut MEDLINE: Olanzapine, Lipid Metabolism, Weight Gain. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 57 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

As one of the most common antipsychotics, olanzapine may cause metabolic‐related adverse effects, but it is still unknown how olanzapine alters lipid metabolism. In this study, we found that olanzapine‐treated mice showed varying degrees of dyslipidemia, which was particularly pronounced in female mice. Based on ultra‐performance liquid chromatography–quadrupole time‐of‐flight–MS (UPLC–Q‐TOF–MS) technology and lipid metabolomics, we mapped the changes in lipid metabolism in olanzapine‐treated mice and then compared the changes in lipid metabolism between male and female mice. There were 98 metabolic differentiators between the olanzapine‐treated and control groups in females and 79 in males. These metabolites were glycerolipids, glycerophospholipids, fatty amides, and sphingolipids, which are involved in glycerolipid metabolism, glycerophospholipid metabolism, and fatty acid metabolism. These results suggest that olanzapine‐induced changes in the levels of lipid metabolites are closely associated with disturbances in lipid metabolic pathways, which may underlie lipemia. This lipidome profiling study not only visualizes changes in lipid metabolism in liver tissue but also provides a foundation for understanding the regulatory pathways and mechanisms involved in olanzapine‐induced lipid metabolism disorders. Furthermore, this study demonstrates differences in lipid metabolism between males and females, providing a reference for clinical treatment regimen selection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OlanzapineLipid MetabolismWeight GainAnimalsFemaleMaleMiceChromatography, High Pressure LiquidLipidomicsMice, Inbred C57BLLiverSex FactorsBenzodiazepinesMass SpectrometryDyslipidemiasAntipsychotic AgentsLipids

Stichwörter der Autor:innen

dyslipidemialipidomicsolanzapineschizophrenia

Substanzen

OlanzapineBenzodiazepinesAntipsychotic AgentsLipids

Autor:innen und Institutionen

  • School of Medicine, Shanghai University, Shanghai, China.
  • School of Life Sciences, Shanghai University, Shanghai, China.
  • Zhanjiang Institute of Clinical Medicine, Central People's Hospital of Zhanjiang, Zhanjiang, China.
  • Institute of Translational Medicine, Shanghai University, Shanghai, China.
  • Division of Mood Disorders, Shanghai Hongkou Mental Health Center, Shanghai, China.
  • Clinical Research Center for Mental Health, School of Medicine, Shanghai University, Shanghai, China.

ORCID-Profile: Tong Zhu, Songyan Gao

Zitieren

APA

Zhu, T., Zhao, H., Chao, Y., Gao, S., Dong, X., & Wang, Z. (2024). Olanzapine‐induced weight gain and lipid dysfunction in mice between different gender. Biomedical Chromatography. https://doi.org/10.1002/bmc.5864

Vancouver

Zhu T, Zhao H, Chao Y, Gao S, Dong X, Wang Z. Olanzapine‐induced weight gain and lipid dysfunction in mice between different gender. Biomedical Chromatography. 2024. doi:10.1002/bmc.5864

BibTeX
@article{Zhu2024,
  author = {Zhu, Tong and Zhao, Hongxia and Chao, Yufan and Gao, Songyan and Dong, Xin and Wang, Zuowei},
  title = {Olanzapine‐induced weight gain and lipid dysfunction in mice between different gender},
  journal = {Biomedical Chromatography},
  year = {2024},
  doi = {10.1002/bmc.5864}
}
Kostenlos starten →